This inventor holds 1 USPTO granted patent. Top assignee: Amsilk Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Sebastian Remmensee in Microfluidic Technology
Introduction: Sebastian Remmensee is an inventive mind based in Munich, Germany, recognized for his groundbreaking work in the field of biotechnology. His most notable contribution is a patent that focuses on the controlled aggregation of spider silk proteins, which highlights the potential of biomaterials in various applications.
Latest Patents: Remmensee holds a patent for a microfluidic device aimed at controlling the phase separation of one or more spider silk proteins. This invention leads to the defined and controllable assembly of the silk proteins into specific morphologies, such as spheres, nanofibrils, and threads. This innovation showcases Remmensee’s commitment to exploring the utility of spider silk, a remarkable natural material.
Career Highlights: Currently, Sebastian is associated with Amsilk GmbH, a company at the forefront of biotechnological advancements. His role involves leveraging his expertise in microfluidic technologies to explore new applications for spider silk, which is known for its strength and versatility.
Collaborations: Throughout his career, he has collaborated with notable peers, including Thomas Scheibel and Daniel Huemmerich. These collaborations enhance the research and development endeavours at Amsilk and contribute to the advancement of biotechnology.
Conclusion: Sebastian Remmensee is a notable inventor in the realm of microfluidic technology and biomaterials. His innovative patent for a microfluidic device reflects his dedication to harnessing the potential of spider silk. As he continues to collaborate with his colleagues at Amsilk GmbH, the impact of his work on both the scientific and commercial landscapes remains significant.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
